upadacitinib,linaclotide,risankizumab
Abbvie,ironwood pharmaceutical,Boehringer Ingelheim
['$abbv', 'abbvie']
$abbv abbvie releases new data demonstrating breadth of its gastroenterology portfolio at 2023 digestive disease week 45 seconds delayed.
Democratizing insights.

Not investment advice.